Cymbalta (duloxetine) works better than Lyrica (pregabalin) for diabetic peripheral neuropathy.

This comes from a new head-to-head study comparing Cymbalta 60 mg/day with Lyrica 300 mg/day...the FDA-approved doses.

The trouble is some experts think Lyrica 600 mg/day works better than 300 mg/day...although it’s harder to tolerate.

But neither is necessarily a first-line choice.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote